课题基金 / 基金详情

DOSE RANGING AND EFFICACY OF UP 269-6 IN HYPERTENSIVE PATIENTS

DOSE RANGING AND EFFICACY OF UP 269-6 IN HYPERTENSIVE PATIENTS
UP 269-6 在高血压患者中的剂量范围和疗效
批准号：
3743977
负责人：
EDWARD C. CONRADI
金额：
$0.0万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3743977
关键词：
angiotensins antihypertensive agents cardiovascular disorder chemotherapy drug screening /evaluation human subject human therapy evaluation hypertension inhibitor /antagonist

项目摘要

项目成果

EDWARD C. CONRADI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a dose ranging short term study of a new angiotensin antagonist, similar to Losartin. This phase II multicenter study will be conducted with 12 disease free hypertensive patients. This is the first time this drug will be administered to humans with hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ISRADIPINE, ENALAPRIL & ATENOLOL EFFECTS ON ELDERLY FEMALE PATIENTS
DILTIAZEM ER DOSE RESPONSE IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
COMPARING EFFICACY AND TOLERABILITY OF FELODIPINE AND VERAPAMIL
ANTIHYPERTENSIVE EFFICACY AND SAFETY OF DIFFERENT DUP-753 (MK954) DOSES
海外基金